Uncategorized
VIDEO: Preliminary study of Ozurdex for CME, proliferative retinopathy encouraging
BALTIMORE — At the Association for Research in Vision and Ophthalmology meeting here, Angelo Minnella, MD, of Catholic University of the Sacred Heart in Rome, discusses 6-month results of Ozurdex (dexamethasone intravitreal implant, Allergan) for the treatment of patients with macular edema and proliferative retinopathy.